Casana Announces the Appointment of Shikha Anand, M.D., As Chief Medical Officer

Dr. Anand brings deep experience in developing patient-centered solutions to improve health; Company pursues second FDA clearance

ROCHESTER, N.Y., June 13, 2023 (GLOBE NEWSWIRE) — Today, Casana, the industry leader in monitoring heart health through smart toilets, announced the appointment of Shikha Anand, M.D. MPH, as Chief Medical Officer. Casana is dedicated to health improvement through effortless home monitoring. Casana’s Heart Seat™ helps people and their care teams capture FDA cleared clinical values, including heart rate and blood oxygenation. Casana is pursuing future clinical measurements in development, such as blood pressure. The company has raised $46M to date to accelerate the product’s development and go-to-market strategy.

Dr. Anand brings more than 20 years of experience evaluating and launching tools to help people improve their health in their homes and communities. Her leadership experience includes public health, research, consumer health technology, health equity, and clinical informatics. Prior to joining Casana, Dr. Anand served as the Chief Medical Officer at Well, the on-demand healthcare guidance platform, and Withings, a world leader in connected health technology. She has used her clinical, research, and data science expertise to lead initiatives to develop novel technology and algorithms to screen, diagnose, and monitor chronic medical and behavioral health conditions at these companies, as well as Federally Qualified Health Centers, Aetna/ CVS, and Walmart’s Care Clinics.

“Dr. Anand’s patient-centric approach not only aligns with our mission, but is exactly what we need in order to understand how this unique technology will resonate with our audience,” said Austin McChord, CEO of Casana. “Her dedication to empowering users from all backgrounds to take charge of their health using a data-driven approach will be instrumental here at Casana.”

As Casana plans to file future indications this year, including Systolic and Diastolic Blood Pressure (BP), Dr. Anand will focus on delivering clinical guidance to the business and establishing key commercial partnerships in advance of an initial U.S. product launch. She will also support Casana’s rigorous scientific approach and strong research partnerships with renowned institutions such as The Villages, UMass Chan Medical School’s Program in Digital Medicine, the Rochester Institute of Technology and others.

“I’m eager to collaborate with Casana’s leadership, as well as their strong network of partners to bring effortless measurement into the home,” said Dr. Anand. “Casana has an innovative team already, and I’m thrilled to complement this innovation with a strong medical strategy.”

For more information or to stay up to date on the product’s market launch, subscribe for updates here.

About Casana:

Casana is innovating healthcare delivery with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The FDA cleared Heart Seat™ captures heart rate and blood oxygenation. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along.

The Heart Seat will become commercially available upon future clearance of non-invasive blood pressure.

Contact:

Danielle Lewan

Director of Marketing & Communications

dlewan@casanacare.com

The Heart Seat is a replacement for a standard toilet seat that is indicated for use in a home environment. The Heart Seat is intended to be used for measuring, displaying, reviewing, and storing non-invasive functional oxygen saturation of arterial hemoglobin (SpO2) and heart rate (HR) in adults of at least 22 years of age with weight ranging from 90 to 350 pounds. Data from the Heart Seat are collected whenever the seat is used and are automatically uploaded to the Casana Cloud where they can be viewed by the healthcare provider. The Heart Seat is not intended for continuous monitoring.